Revolution Medicines’ stock has surged on the promise of a pancreatic-cancer drug. With any deal to buy the firm looking ...
Kissht has trimmed its IPO size to Rs 926 crore, reducing fresh issue and OFS amid changing market conditions and investor ...
Zacks Investment Research on MSN
Vertex Pharmaceuticals (VRTX) earnings expected to grow: What to know ahead of next week's release
The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year increase in earnings on higher revenues when it ...
CRSP eyes a Q1 beat as rising Casgevy uptake, improving sales outlook and a strong Earnings ESP set the stage ahead of results.
Through the Gemini Enterprise Agent Platform – the enhanced and rebranded Vertex AI – developers have options for building ...
OnEMI Technology Solutions Ltd, which operates digital lending platform Kissht, on Monday fixed a price band of ₹162-171 per ...
The notable startup funding rounds for the week ending 4/25/26 featuring funding details for Omni, Archil, Schematic, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results